Search results
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its...
Simply Wall St. via Yahoo Finance· 4 months agoThe analysts might have been a bit too bullish on Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), given...
Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting...
Simply Wall St. via Yahoo Finance· 4 weeks agoTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) just released its latest first-quarter results and things...
Analysts' Revenue Estimates For Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Are Surging Higher
Simply Wall St. via Yahoo Finance· 1 year agoCelebrations may be in order for Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shareholders, with the...
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoAtea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript November 8, 2023 Atea...
Industry Analysts Just Upgraded Their Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Revenue Forecasts...
Simply Wall St. via Yahoo Finance· 2 years agoRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) shareholders will have a reason to smile today, with the...
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Just Reported And Analysts Have Been Lifting Their Price...
Simply Wall St. via Yahoo Finance· 2 years agoIt's been a good week for Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) shareholders, because the...
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Analysts Just Trimmed Their Revenue Forecasts By 10%
Simply Wall St. via Yahoo Finance· 2 years agoMarket forces rained on the parade of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) shareholders today,...
Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its...
Simply Wall St. via Yahoo Finance· 1 month agoUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) just released its latest first-quarter report and...
Analysts Are Updating Their Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Estimates After Its...
Simply Wall St. via Yahoo Finance· 1 month agoThere's been a notable change in appetite for Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shares in...